tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Entera Bio Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsEntera Bio Reports Q3 2025 Financial Results
3M ago
Entera Bio Reports Q3 2025 Results and FDA Agreement
Premium
Company Announcements
Entera Bio Reports Q3 2025 Results and FDA Agreement
3M ago
Entera Bio presents clinical data from EB613 Phase 2 trial
Premium
The Fly
Entera Bio presents clinical data from EB613 Phase 2 trial
4M ago
Entera Bio’s Promising Phase 3 Study and Market Potential Drive Buy Rating
PremiumRatingsEntera Bio’s Promising Phase 3 Study and Market Potential Drive Buy Rating
6M ago
Entera Bio Reports Q2 2025 Financial Results and Strategic Progress
Premium
Company Announcements
Entera Bio Reports Q2 2025 Financial Results and Strategic Progress
6M ago
Entera Bio Reports Q2 2025 Financial Results
Premium
Company Announcements
Entera Bio Reports Q2 2025 Financial Results
6M ago
Entera Bio, Opko Health announce new in vivo data for OPK-88006
PremiumThe FlyEntera Bio, Opko Health announce new in vivo data for OPK-88006
8M ago
Opko Health, Entera Bio say OPK-88006 data selected for ENDO 2025
Premium
The Fly
Opko Health, Entera Bio say OPK-88006 data selected for ENDO 2025
8M ago
Entera Bio files $100M mixed securities shelf
Premium
The Fly
Entera Bio files $100M mixed securities shelf
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100